<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05612997</url>
  </required_header>
  <id_info>
    <org_study_id>ZOE-AFFIRM</org_study_id>
    <nct_id>NCT05612997</nct_id>
  </id_info>
  <brief_title>ZOE-AFFIRM: Relative Validation of a Novel Food Frequency Questionnaire</brief_title>
  <official_title>Relative Validation of a Remote Novel Food Frequency Questionnaire Compared to 24hr Recalls in the ZOE AFFIRM Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zoe Global Limited</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dietary assessment is critical for dietary research. Food Frequency Questionnaires (FFQ)&#xD;
      measure habitual dietary intake and are low user and researcher burden. The ZOE AFFIRM study&#xD;
      aims to assess the relative validity of a novel FFQ compared to a widely accepted 24h dietary&#xD;
      recall tool in a remote setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research Question:&#xD;
&#xD;
      What is the relative validity of a novel FFQ (Food Frequency Questionnaire) compared to a&#xD;
      widely accepted 24h dietary recall tool in a remote setting?&#xD;
&#xD;
      Research Aim:&#xD;
&#xD;
      This study aims to relatively validate the ZFFQ (ZOE Food Frequency Questionnaire; ZOE Ltd)&#xD;
      by assessing its agreement with a widely accepted 24h diet recall tool, Intake24 (Newcastle&#xD;
      University) in a remote population.&#xD;
&#xD;
      Design:&#xD;
&#xD;
      This study will be conducted in a single-arm design with the intake period under assessment&#xD;
      comprising one month.&#xD;
&#xD;
        1. Participants will complete two periods of 3 consecutive days each (one weekend-day and&#xD;
           two weekdays, i.e. Sunday-Tuesday or Thursday-Saturday), in which they will complete 6&#xD;
           total rounds of Intake24 (one completion per previous 24 hours). The two periods must be&#xD;
           at least 14 days apart; participants will be given multiple options of dates to choose&#xD;
           from in November/December that satisfy these requirements.&#xD;
&#xD;
        2. Once the two recall periods are completed, the participant will be asked to fill out the&#xD;
           ZFFQ recalling food frequency (without portion sizes) over the preceding month (which&#xD;
           encompasses the two recall periods).&#xD;
&#xD;
      Population: In brief, participants are generally healthy UK-based adults who provided consent&#xD;
      to participation in this remote study. Please see the eligibility section for full criteria.&#xD;
      Participants provided consent before undertaking any study procedures.&#xD;
&#xD;
      Data analysis: Agreement analysis will be used to compare both dietary assessment methods and&#xD;
      evaluate the relative validity of the ZOE FFQ.&#xD;
&#xD;
      Data collection:&#xD;
&#xD;
        -  Baseline demographic data (age, sex, BMI, ethnicity, smoking, socio-economic status)&#xD;
&#xD;
        -  Dietary data (FFQ and 24hr dietary recall)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 8, 2022</start_date>
  <completion_date type="Anticipated">December 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Food Frequency Questionnaire</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>24h Recalls</measure>
    <time_frame>6 days</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Diet Habit</condition>
  <arm_group>
    <arm_group_label>Relative Validation Arm</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Assessment</intervention_name>
    <description>Food Frequency Questionnaire and 24h Recalls.</description>
    <arm_group_label>Relative Validation Arm</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        United Kingdom-based adult population who have subscribed to the ZOE Product waitlist.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Can provide written informed consent&#xD;
&#xD;
          -  Are willing and able to comply with all study protocols&#xD;
&#xD;
          -  Are willing to complete their dietary recall periods on specified dates&#xD;
&#xD;
          -  Have BMI 18 and above&#xD;
&#xD;
          -  Are any sex&#xD;
&#xD;
          -  Are aged 18 years old and above&#xD;
&#xD;
          -  Live in England, Scotland, Wales or Northern Ireland&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Do not meet the inclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah E Berry, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King's College London and Consultant at ZOE Ltd</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily R Leeming, PhD</last_name>
    <phone>07791131380</phone>
    <email>emily.leeming@kcl.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Inbar Linenberg, MS</last_name>
    <email>inbar.linenberg@kcl.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ZOE Ltd.</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>November 4, 2022</study_first_submitted>
  <study_first_submitted_qc>November 4, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 4, 2022</last_update_submitted>
  <last_update_submitted_qc>November 4, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

